RecruitingPhase 1NCT04389632
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Calumet City, IL · Chicago, IL · +103 more sites
1 recruiting breast cancer studies with a site in Calumet City, IL.
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Calumet City, IL · Chicago, IL · +103 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.